PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers

被引：2
|
作者：
Stebbing, Justin [1 ]
Ellis, Paul [2 ,3 ]
Tutt, Andrew [4 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Oncol & Surg, London W12 0NN, England
[2] Guys & St Thomas NHS Trust, Dept Oncol, London, England
[3] Kings Coll Hosp, London, England
[4] Guys Hosp, Breakthrough Breast Canc Res Unit, Kings Hlth Partners AHSC, London SE1 9RT, England
来源：
FUTURE ONCOLOGY | 2010年 / 6卷 / 04期
关键词：
breast cancer; BRCA; PARP inhibitor; triple negative; POLY(ADP-RIBOSE) POLYMERASE; RESISTANCE; DNA; REPAIR; MUTATIONS; TUMORS; BRCA1;
D O I：
10.2217/FON.10.27
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：485 / 486
页数：2
相关论文
共 50 条
  • [1] Are BRCA1- and BRCA2-associated breast cancers different?
    Offit, K
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 104S - 106S
  • [2] Current perspectives on BRCA1- and BRCA2-associated breast cancers
    Phillips, KA
    INTERNAL MEDICINE JOURNAL, 2001, 31 (06) : 349 - 356
  • [3] Evidence That BRCA1- or BRCA2-Associated Cancers Are Not Inevitable
    Levin, Bess
    Lech, Denise
    Friedenson, Bernard
    MOLECULAR MEDICINE, 2012, 18 (09) : 1327 - 1337
  • [4] Evidence That BRCA1- or BRCA2-Associated Cancers Are Not Inevitable
    Bess Levin
    Denise Lech
    Bernard Friedenson
    Molecular Medicine, 2012, 18 : 1327 - 1337
  • [5] Are BRCA1- and BRCA2-associated breast cancers different?: Prognosis of BRCA1-associated breast cancer
    Robson, M
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 113S - 118S
  • [6] Histopathology of BRCA1- and BRCA2-associated breast cancer
    Honrado, Emiliano
    Benitez, Javier
    Palacios, Jose
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 59 (01) : 27 - 39
  • [7] Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections
    Fountzilas, Elena
    Konstantopoulou, Irene
    Vagena, Andromahi
    Apostolou, Paraskevi
    Papadimitriou, Christos
    Christodoulou, Christos
    Tryfonopoulos, Dimitrios
    Manousou, Kyriaki
    Delimitsou, Angeliki
    Papamentzelopoulou, Myrto
    Fountzilas, Georgios
    Yannoukakos, Drakoulis
    Fostira, Florentia
    CLINICAL BREAST CANCER, 2020, 20 (02) : 152 - 159
  • [8] ERBB2 and MYC alterations in BRCA1- and BRCA2-associated cancers
    Palacios, J
    Honrado, E
    Cigudosa, JC
    Benítez, J
    GENES CHROMOSOMES & CANCER, 2005, 42 (02): : 204 - 205
  • [9] Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinoma
    Hamilton, LJ
    Evans, AJ
    Wilson, ARM
    Scott, N
    Cornford, EJ
    Pinder, SE
    Khan, HN
    Macmillan, RD
    CLINICAL RADIOLOGY, 2004, 59 (10) : 895 - 902
  • [10] Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
    Jan C. Drooger
    Bernadette A. M. Heemskerk-Gerritsen
    Nyrée Smallenbroek
    Cynthia Epskamp
    Caroline M. Seynaeve
    Agnes Jager
    Breast Cancer Research and Treatment, 2016, 156 : 557 - 566
12345